Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

CoQ10 showdown: which supplement boosts your cells best?

NCT ID NCT06640465

Knowledge-focused Sponsor: OvationLab Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested four different CoQ10 supplements (ubiquinol, ubiquinone, geranylgeraniol, and a combo) against a placebo in 150 healthy adults aged 40 and older. The goal was to see which supplement safely increases CoQ10 levels in the blood and improves self-reported health over 8 weeks. The study also checked blood markers like cholesterol and liver function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CoQ10 supplements (ubiquinol, ubiquinone, geranylgeraniol)
What this could lead to
If successful, this could show which CoQ10 supplement best boosts CoQ10 levels, possibly guiding healthier aging choices.
What could go wrong
This is a small, early-phase trial in healthy people, so results may not apply to those with medical conditions. Supplements may not improve actual health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

150 people

The number who actually took part.

Started

Oct 2024

Finished

Sep 2025

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult males or females age ≥ 40 years 2. Ability to read and speak English Exclusion Criteria: 1. Daily use within the past 2 months of any dietary supplements containing CoQ10 or geranylgeraniol (GG) 2. Taking a statin medication within the past 6 months 3. Current daily usage of H2 blockers or PPI medications 4. Current daily use of bisphosphonates 5. Current daily tobacco smoker 6. Known allergies to any substance in the study products 7. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks 8. Current diagnosis of a chronic health condition (e.g., cancer, Crohn's disease) deemed clinically contraindicated for the study protocol. 9. Participant in a clinical trial in the previous 30 days. 10. Participants unable to provide consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health Wellness

Contacts and locations

Locations

  • CTMD Research

    Palm Springs, Florida, 33046, United States

  • Cornerstone Health Community

    Centennial, Colorado, 80111, United States

  • Functional Medicine of Idaho

    Eagle, Idaho, 83616, United States

  • New Dawn Wellness and Medical Center

    Houston, Texas, 77082, United States

  • True Health Center for Precision Medicine

    El Dorado Hills, California, 95762, United States

  • Vida Integrated Health

    Seattle, Washington, 98122, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.